This article is a correction to:
Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?
Magdalena Więdłocha1,2*
Piotr Marcinowicz1,2Jan Komarnicki3
Małgorzata Tobiaszewska4
Weronika Dębowska1Marta Dębowska1
Agata Szulc1,5- 1Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Pruszkow, Masovian, Poland
- 2KeyClinic, Warsaw, Poland
- 3Leszek Giec Upper-Silesian Medical Centre of the Medical University of Silesia, Katowice, Poland
- 4Medical University of Warsaw, Warsaw, Masovian, Poland
- 5MindHealth, Warsaw, Poland
A Corrigendum on
Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?
By Więdłocha M, Marcinowicz P, Komarnicki J, Tobiaszewska M, Dębowska W, Dębowska M and Szulc A (2024) Front. Psychiatry 15:1398859. doi: 10.3389/fpsyt.2024.1398859
In the published article, there was an error in the affiliations for authors Magdalena Więdłocha, Piotr Marcinowicz and Agata Szulc. Two affiliations were not disclosed. Authors MW and PM were employed by KeyClinic. Author AS was employed by Mindhealth.
In the published article, there was an error in the Conflict of Interest statement, which previously stated:
“The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”
The corrected statement appears below:
“Authors MW and PM were employed by the company KeyClinic, a commercial mental health center which provides ketamine treatment, as one of many services. Author AS was employed by the company MindHealth, a commercial psychiatric center. AS was also a member of Janssen Cilag Advisory Board and gave lectures for Janssen Cilag.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: ketamine, esketamine, depression, treatment resistant depression (TRD), borderline personality disorder, ketamine-assisted psychotherapy (KAT)
Citation: Więdłocha M, Marcinowicz P, Komarnicki J, Tobiaszewska M, Dębowska W, Dębowska M and Szulc A (2024) Corrigendum: Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst? Front. Psychiatry 15:1507504. doi: 10.3389/fpsyt.2024.1507504
Received: 07 October 2024; Accepted: 08 October 2024;
Published: 28 October 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Więdłocha, Marcinowicz, Komarnicki, Tobiaszewska, Dębowska, Dębowska and Szulc. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Magdalena Więdłocha, bWdkd2llZGxvY2hhQGdtYWlsLmNvbQ==